Company Profile

Luminex Corporation is a United States-based company that is a biotechnology company. The Company is involved in developing, manufacturing and marketing biological testing technologies in the clinical diagnostic and life science industries. Its offer a solution applicable in the markets, including clinical diagnostics, pharmaceutical drug discovery, genomic and proteomic research, biomedical research and food safety.

Employees

1,325

Sector

Advanced Medical Equipment & Technology

More about the company

06-02	SMi Systems and Luminex Corporation Execute Non-Exclusive Evaluation Collaboration	CI
28/02/23	Cytek Biosciences, Inc. completed the acquisition of Flow Cytometry & Imaging business unit of Luminex Corporation for $44.9 million.	CI
14/02/23	Cytek Biosciences, Inc., Luminex Corporation - M&A Call
13/02/23	Cytek Biosciences, Inc. entered into an agreement to acquire Flow Cytometry & Imaging business unit of Luminex Corporation for $46.5 million.	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 Health Care	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 1000	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P TMI Index	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Global BMI Index	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Composite 1500	CI
15/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600	CI
14/07/21	Luminex Corporation Announces Executive Changes	CI
14/07/21	Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Composite Index	CI
14/07/21	DiaSorin S.p.A. completed the acquisition of Luminex Corporation from BlackRock, Inc., Biomedical Advanced Research And Development Authority, The Vanguard Group, Inc., RGM Capital, LLC and others.	CI

13/04/21	LUMINEX : Piper Sandler Downgrades Luminex to Neutral From Overweight; Price Target is $37	MT
13/04/21	LUMINEX : BTIG Downgrades Luminex to Neutral From Buy	MT

21/04/22	Luminex Resources Upsizes Private Placement to C$9M, Ross Beaty to Invest C$1.8 Million	AQ
15/03/22	Luminex Discovers High-grade Zone Adjacent to Los Cuyes Resource, First Hole Intercepts 8.60m at 5.39 gt AuEq	AQ
01/02/22	The Microbiome Test from Genetic Analysis AS launched on a new technology platform, GA-map® Dysbiosis Test kit now commercially available on the Luminex MAGPIX® system	AQ
27/09/21	Luminex Resources : Discovers a New Porphyry Copper Target at Cascas	AQ
29/07/21	Luminex Resources : Announces Positive Condor North Preliminary Economic Assessment, US$387 Million NPV, 12 Year Mine Life and Production of 187 Koz Gold per Year	AQ

12/04/21	Beperkte verliezen op Wall Street
12/04/21	DiaSorin S p A : Schwäbischer Kunststoff-Konzern Ritter für 890 Mio Euro verkauft
12/04/21	Dow Jones Industrial Average : Les valeurs à suivre à Wall Street
12/04/21	DiaSorin S.p.A. : le marché salue le rachat de Luminex
12/04/21	DiaSorin S p A : si rafforza negli Usa e rileva Luminex per 1,8 mld $, titolo corre

Manager	Title	Age	Since
Angelo Rago PSD	President	-	01/04/2022
Andrea Giubboni DFI	Director of Finance/CFO	-	01/09/2021
John Hoffarth TRE	Treasurer	-	14/07/2021

Luminex Corporation Stock

Stocks

LMNX

US55027E1029

Advanced Medical Equipment & Technology

Latest news : Luminex Corporation

Analysts' recommendations: Luminex Corporation

Press Releases: Luminex Corporation

News in other languages: Luminex Corporation

Quotes and Performance

Managers and Directors: Luminex Corporation

Latest insider transactions

Other Advanced Medical Equipment & Technology

Company Profile

Director	Title	Age	Since
John Hoffarth BRD	Director/Board Member	-	14/07/2021
Loewenbaum Wally CHM	Chairman	-	01/10/2002

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/14/21 A	Todd Bennett	Issuer sale	Responsable ventes & marketing	164,276	0.3472%
7/14/21 A	Stephen Eck	Issuer sale	Director	38,073	0.0805%
7/14/21 A	Harriss Currie	Issuer sale	Chief Financial Officer	615,809	1.3016%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LUMINEX CORPORATION	+0.03%	+0.49%	-	-	1.74B
THERMO FISHER SCIENTIFIC, INC.	-1.97%	+1.03%	+28.39%	+1.68%	198B
DANAHER CORPORATION	-0.58%	+2.40%	+7.25%	-15.35%	144B
INTUITIVE SURGICAL, INC.	-14.15%	-15.08%	-33.40%	-2.68%	122B
BOSTON SCIENTIFIC CORPORATION	-1.32%	-1.65%	-57.52%	-16.63%	65.44B
EDWARDS LIFESCIENCES CORPORATION	-2.40%	-7.03%	+12.08%	-6.81%	49.36B
SIEMENS HEALTHINEERS AG	-0.11%	+1.53%	-23.83%	-30.51%	44.74B
AGILENT TECHNOLOGIES, INC.	-3.41%	-2.11%	+15.33%	+9.95%	37.13B
WATERS CORPORATION	-2.44%	-1.98%	+28.33%	+35.71%	36.23B
RESMED, INC.	-1.86%	-2.39%	-22.85%	-10.01%	28.7B
Average	-2.82%	-2.32%	-5.14%	-3.85%	80.68B
Weighted average by Cap.	-3.69%	-1.84%	-0.99%	-4.99%